Executive Leadership
Russell Scheffer, MD
Chief Executive Officer
rscheffer@kumc.edu
Sheldon H. Preskorn, MD
President
spreskorn@cri-research.net
In addition to serving as President of the Clinical Research Institute, Dr. Preskorn is also Professor for the Department of Psychiatry at the University of Kansas School of Medicine - Wichita.
Dr. Preskorn has conducted preclinical pharmacology studies for over 10 years and has served as the principal investigator for over 250 formal clinical trials covering all phases of human studies for nearly 30 years including first in man studies, single dose and multiple dose ascending trials, first in mildly symptomatic volunteers studies in a variety of different special populations, pharmacokinetic-pharmacodynamic studies with various endpoints for drug effect, drug-drug interaction studies, formulation studies, phase II and phase III studies in various therapeutic areas. These include drug development studies of all of the marketed antidepressants in the United States during the last 25 years. He has also been involved in the registration process for seven of these drugs.
A fellow of the American Psychiatric Association and the American Psychopathological Association, Dr. Preskorn has served on the Food and Drug Administration psychopharmacology advisory committee, Veterans Administration, National Institutes of Health, and National Science Foundation. He has also served as a consultant to the regulatory equivalent for the FDA for the European Union, Australia, Great Britain, Japan, and Sweden.
Dr. Preskorn has assisted and represented many pharmaceutical companies in presenting to both the FDA psychopharmacology advisory committee and the FDA Over-the-Counter advisory committee. He has represented companies at FDA labeling conferences and consulted with various companies and their legal firms on product liability cases, patent infringement cases. He has also consulted on US and international marketing and educational projects.
An international lecturer and author of over 350 scientific and professional articles, Dr. Preskorn has received continuous grant funding since 1978, allowing him to conduct research primarily in the areas of psychopharmacology, affective and anxiety disorders, and neuroscience.
His basic pharmacological and neuroscience research has included studies in neurochemistry, neurophysiology, histochemistry, electron microscopy, cerebral blood flow and metabolism, positron emission tomography and radioligand binding. His clinical research has included pharmacokinetics and drug development through all clinical phases.
Clinical
Jennifer Hubbard, RN, BSN
Clinical Research Coordinator
2 years of experience
E-mail: jhubbard@cri-research.net
